Journal of Advanced Biotechnology and Experimental Therapeutics - Similar companies

About JABET Journal of Advanced Biotechnology and Experimental Therapeutics (JABET) – is an open access, international, peer- ... reviewed, scientific journal publishing original research findings and reviews on all aspects of biotechnology and experimental therapeutics. It provides a platform for Scientists and Academicians all over the world to promote, share, and discuss various new issues and developments in translational research and recent discoveries in the Biotechnology and Biomedical Sciences. • Short name: J Adv Biotechnol Exp Ther • Electronic ISSN: 2616-4760 • Year of starting: September 2017, first issue- January 2018 • License type: Free for non-commercial use (CC-BY-NC 4.0), [OPEN ACCESS] • Country of publication: South Korea The vision of our journal is to ‣ Upgrade the awareness among experts and the young scientists about modern breakthroughs and emerging opportunities in biotechnology and Biomedical research. ‣ Establish rapid peer review processes to accelerate the publication of excellent research papers of their interest. ‣ Meet the vigorously increasing demand for essential biotechnological and medical information by disseminating significant advances and grand results of scientific works and discoveries to the broader global health community. ‣ Assist in the dissemination of journal content to the global arena. ‣ Contribute to publishing high-quality research data for the improvement of overall livelihood of the world population. ‣ Aid scientists and global audience through prompt publication of rigorous peer-reviewed articles. read more